Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0IL0H
|
|||
| Former ID |
DIB008963
|
|||
| Drug Name |
MaC46/M87o
|
|||
| Synonyms |
HIV-1 infection gene therapy, Georg-Speyer-Haus
Click to Show/Hide
|
|||
| Indication | Human immunodeficiency virus-1 infection [ICD-11: 1C62; ICD-10: B20-B24] | Phase 1/2 | [1] | |
| Company |
Takara bio
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Human immunodeficiency virus Glycoprotein 41 (HIV gp41) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Creating genetic resistance to HIV. Curr Opin Immunol. 2012 Oct;24(5):625-32. | |||
| REF 2 | DOI: 10.1038/mt.sj.6300124 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.